Tolerability of the niraparib individualized starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy
耐受性
第一行
医学
内科学
不利影响
作者
Christof Vulsteke,Setsuko K. Chambers,M.J. Rubio Pérez,John K. C. Chan,Nicoline Raaschou‐Jensen,Ying Zhuo,Domenica Lorusso,Thomas J. Herzog,Thibault De La Motte Rouge,Jessica A. Thomes Pepin,Elena Ioana Braicu,Lee-may Chen,Tally Levy,James Barter,Maria-Pilar Barretina-Ginesta,E. Joosens,Whitney York,Izabela A. Malinowska,Antonio González-Martı́n,Bradley J. Monk